Originally Published EMDM November/December
2004
Industry News
Chrome Coating Meets Latest ISO Standards |
| Biomedical chrome coating Medcoat 2000 has met the new ISO test parameters. |
In the rigorous world of medical device testing, changing standards reflect
evolving ideas about the best methods to ensure safety. Medcoat 2000, a biomedical
chrome coating, recently rose to the challenge of new ISO test parameters that
require the evaluation of coating performance in oil rather than saline.
North American Science Associates Inc. (NAMSA; Northwood, OH, USA) determined
that the product did not induce delayed dermal contact sensitization in living
animal tissue. Among key results of various biological compatibility tests,
Medcoat 2000’s manufacturer notes that the coating produces no systemic
toxicity, no localized tissue reaction, and no irritation to human tissue, thereby
meeting the USP Class VI toxicity requirements.
“The Electrolizing Corp. of Ohio (Cleveland, OH, USA) specializes
in medical coatings,” says general manager Bill Loucks, “and Medcoat
2000 represents our commitment to developing new and better products for the
medical device industry.” He adds that the corporation relies heavily on
independent testing of its coatings.
For more information, contact The Electrolizing Corp. of Ohio, 1325 E. 152nd
St., Cleveland, OH 44112, USA; phone: +1 216 4518655; fax: +1 216 4514729; e-mail:
nnoble@normannoble.net; Internet:
www.medcoat2000.com.
Copyright ©2004
European Medical Device Manufacturer
